Showing results (661-670 of 1,600) with videos related to
Sort By:
Pageof 160
RSC Medicinal Chemistry|September 12, 2025
Indazole - an emerging privileged scaffold: synthesis and its biological significanceAnuradha Singampalli, Pardeep Kumar, Rani Bandela, et al.RSC Medicinal Chemistry|September 10, 2025
Targeting Tumor-Associated Hypoxia with Bioreductively Activatable Prodrug Conjugates Derived from Dihydronaphthalene, Benzosuberene, and Indole-based Inhibitors of Tubulin PolymerizationZhe Shi, Rajsekhar Guddneppanavar, Blake A Winn, et al.RSC Medicinal Chemistry|February 9, 2026
Discovery of a CHI3L1-targeted small molecule modulating neuroinflammation in Alzheimer's disease via DNA-encoded library (DEL) screeningBaljit Kaur, Longfei Zhang, Hossam Nada, et al.RSC Medicinal Chemistry|February 16, 2026
Leveraging fragment-based drug discovery to advance 3D scaffolds into potent ligands: application to the histamine H1 receptorTom Dekker, Oscar P J van Linden, Herman D Lim, et al.RSC Medicinal Chemistry|February 5, 2026
2,5-Diazabicyclo[2.2.1]heptane in medicinal chemistry: a treasure trove of therapeutic opportunitiesPranav Kumar Ambast, Saumya Kapoor, Rudradip Das, et al.RSC Medicinal Chemistry|August 4, 2025
Target agnostic cellular screening in the era of chemically induced proximityMeizhong JinRSC Medicinal Chemistry|August 4, 2025
Discovery of a potent and selective PROTAC degrader for STAT3Kefeng Wang, Yuxin Zheng, Wenli Mao, et al.RSC Medicinal Chemistry|August 6, 2025
Integrated in silico and experimental screening identifies novel ligands that target precursor microRNA-31 at the dicer cleavage siteGrace Arhin, Lily Haghpassand, Sarah C KeaneRSC Medicinal Chemistry|August 4, 2025
Design, synthesis and biological evaluation of novel bis(indolyl)-tetrazine derivatives as anti-breast cancer agentsKamalpreet Kaur, Harkomal Verma, Prabhakar Gangwar, et al.RSC Medicinal Chemistry|June 27, 2025
Photoswitchable Stat3 inhibitors: design, synthesis and anticancer activity study on 2D and 3D breast cancer cell culturesSatyajit Bera, Subhankar Bose, Nilakshi Paul, et al.Pageof 160